Motiva Implants — A Practical Guide for International Patients

Motiva's SilkSurface is a nanotexture: the surface is microscopically textured at a scale (typically < 100 µm) below the threshold associated with the macro-textured implants linked to BIA-ALCL. Clinically, this puts SilkSurface in a position between fully smooth (rotation risk, more capsule activity) and macro-textured (higher BIA-ALCL signal, now off-market).

For the patient, this matters in two ways: lower BIA-ALCL signal than older macro-textured generations, and reduced capsule-thickening trend over the long term. Neither is a guarantee — it is a difference of degree.

Motiva's Ergonomix gel is the highest-cohesivity variant in their line. The gel is designed to behave more naturally under gravity (returning to a teardrop-like shape when the patient is upright, flattening when supine) without losing structural cohesion under shear.

In practice, this gives a softer feel on palpation than the older "highly cohesive" generations and a more natural upper-pole slope when the patient is standing — without the rotation risk of an anatomical implant. It is a popular choice for patients who want the upright shape of an anatomical with the rotation-safety of a round.

The Motiva Ergonomix vs Round decision is not a ranking. Both are round-based SmoothSilk/SilkSurface options, but their gels behave differently. Ergonomix uses ProgressiveGel Ultima: upright, gravity shifts it toward a teardrop-like lower-pole distribution; supine, it settles into a rounder, flatter profile. Round uses ProgressiveGel Plus for comparatively stable fullness and firmness, tending to retain more upper-pole fill as posture changes. These are tendencies, not promised outcomes.

Ergonomix is generally the softer, more mobile candidate on palpation; Round generally feels firmer and more shape-stable. In low-BMI patients or those with thin tissue, this difference matters but does not decide the case. Softer movement may support a gentle transition, while a form-stable gel may be considered when upper-pole support or edge control is prioritized. Base width, volume, pocket placement, tissue cover, and rippling risk must be assessed together. Thin tissue can make either implant palpable, so neither is an automatic choice or a guarantee against rippling.

Projection is separate from gel type. Motiva names four profiles Mini, Demi, Full, and Corsé, from lower to higher forward projection. A profile describes distance from the chest wall; it is not a cup-size promise or a choice made from volume alone. Consultation should match base width to the chest and tissue envelope, then compare volume and projection within Ergonomix and Round candidates. The table is a discussion frame, not a prescription.

BluSeal is a coloured indicator layer within the implant shell. If shell integrity is ever compromised during handling, the blue layer becomes visible — a manufacturing-side QA step that occasionally catches issues in pre-implantation handling.

The Q Inside is an RFID-readable microchip embedded in the implant. From the patient's perspective, this means implant identification (serial, size, generation) can be confirmed years later via a handheld RFID reader at any follow-up visit — without ultrasound or MRI. For revision patients moving between clinics or countries, this is a meaningful long-term advantage.

Breast implants are not lifetime devices, and an intact implant has no fixed expiration date requiring automatic exchange. Some patients need revision earlier; others keep an implant longer. The practical frame is ongoing follow-up rather than a promised replacement interval: attend examinations recommended by the treating clinic, retain implant records, and seek assessment for pain, firmness, swelling, asymmetry, or a change in breast shape. Imaging or revision decisions depend on the device, symptoms, examination, and current local guidance.

Motiva's published standard structure includes the Always Confident Warranty for rupture during the lifetime of the device and a Product Replacement Policy for Baker grade III or IV capsular contracture for 10 years. "Lifetime of the device" describes a coverage period; it does not mean the implant lasts for life or that a future operation is fully covered. Extended programs may add product replacement and financial assistance, with eligibility tied to implant model, RFID configuration, country or region, surgery date, and registration.

A Motiva warranty is neither a clinical guarantee nor identical in every market. Ask which product will be implanted, what must be registered, which documents you will receive, and what costs or exclusions remain after an accepted claim. Because terms change, confirm current country-specific conditions directly with Motiva instead of relying on another market's summary.

Motiva is typically the right answer for:

• •Patients who want a natural upper-pole slope in the upright position without the rotation risk of anatomical implants.
• •Slim Asian patients with thin soft-tissue cover — the softer Ergonomix behaviour produces less visible upper-pole rippling than older highly-cohesive generations.
• •Patients who plan to move between countries and want straightforward implant identification at future follow-ups via the Q Inside RFID.
• •Patients who want to be away from the older macro-textured class associated with BIA-ALCL signal.

Motiva is not the universal best implant. Mentor still has the longest FDA-approval history and the deepest long-term clinical dataset; for patients who prioritize that depth of historical evidence over newer-generation properties, Mentor is the better answer. Sebbin offers a wider range of anatomical shapes for revision and reconstruction cases where shape control matters more than rotation safety.

A surgeon who recommends Motiva for every patient regardless of anatomy is not making a careful decision. The right implant comes out of the consultation; it should not be assumed at booking.

Motiva has been available in Korea for years and became frequently used during a period of high breast-augmentation activity, giving many surgical teams repeated exposure to its sizing matrix, gel choices, and follow-up records. Frequency does not prove that Motiva or Korea suits one patient. Ask whether the clinic can explain the recommendation alongside alternatives and show how chest width, tissue thickness, asymmetry, incision, and placement change the plan.

For an international patient, remote consultation is a planning screen, not the final surgical decision. Before travel, the clinic can review history, photographs, goals, prior implant records, medications, and time available in Korea. An in-person examination should confirm candidacy, measurements, implant and projection, incision, placement, anesthesia, and return-flight timing before consent. Before departure, obtain the implant card, operative summary, medication and wound instructions, warning signs, and a named remote follow-up route. Arrange local clinical care if examination or imaging may be needed after returning home.

Q Inside can aid cross-border continuity: with a compatible reader, another provider can retrieve device identifiers including serial information and size if a paper card is missing. It neither diagnoses rupture nor replaces examination or imaging. Compare Korea pricing by inclusions, not a headline number; implant model, facility, anesthesia, technique, postoperative visits, medicines, and revision terms can change a quote. The framework at /en/pricing explains cost categories; request a case-specific written quote after assessment.